This CTD dossier owner and manufacturer venture operates in Eastern Asia with EU cGMP approval, specializing in contract manufacturing of high-quality generic medicines. They offer a full range of services from research and development to commercial packaging. Key product areas include solid oral dosage forms like tablets and capsules, with plans to expand into liquids and high-potency preparations. Their expertise covers formulation development, bioequivalence studies, and clinical trial support through partnerships. With over 50 successful technology transfers and nearly 100 registered strengths, the company caters to customers in Europe and Asia.